28/02/2015 11:00:38 Free Membership Login

   

Allergan

Visual Financials
Company Name: Allergan, Inc.
Ticker Symbol: AGN
CIK Number: 850693
WWW Address: http://www.allergan.com
CEO: David Pyott
No. of Employees: 10,800
Common Issue Type: CS
Business Description:Allergan, Inc., is a multi-specialty health care company develops and commercializes innovative pharmaceuticals, biologics and medical devices.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 232.74 Up 0.34 - - 232.06 233.50 232.00 2553122
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 69,877.3 300.2 0.00 5.12 0.20 45.1 0.1 234.68 - 115.94
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close232.79$
PE Ratio - LTM45.1
Market Capitalisation69,877.3mil
Latest Shares Outstanding300.2mil
Earnings pS (EPS)5.12$
Dividend pS (DPS)0.20¢
Dividend Yield0.1%
Dividend Payout Ratio%
Revenue per Employee689,324$
Effective Tax Rate0.2%
Float298.7mil
Float as % of Shares Outstanding1.0%
Foreign Sales2,606mil
Domestic Sales4,521mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.40%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin88.4%
EBITDA Margin31.9%
Pre-Tax Profit Margin27.9%
Assets Turnover63.0%
Return on Assets (ROA)13.3%
Return on Equity (ROE)21.4%
Return on Capital Invested (ROCI)17.0%
Current Ratio4.4
Leverage Ratio (Assets/Equity)1.6
Interest Cover29.7
Total Debt/Equity (Gearing Ratio)0.28
LT Debt/Total Capital21.0%
Working Capital pS17.70$
Cash pS0.00$
Book-Value pS25.82$
Tangible Book-Value pS11.78$
Cash Flow pS6.34$
Free Cash Flow pS5.43$
KEY FIGURES (LTM): Price info
Price/Book Ratio9.06
Price/Tangible Book Ratio0.00
Price/Cash Flow36.9
Price/Free Cash Flow43.1
P/E as % of Industry Group132.0%
P/E as % of Sector Segment102.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of PaymentCash Payment
Dividend Rate0.20
Current Dividend Yield0.1
5-Y Average Dividend Yield0.3
Payout Ratio0.0
5-Y Average Payout Ratio9.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----0.71,824,85210,498,649
4 Weeks234.68217.51218.786.212,009,26940,185,387
13 Weeks234.68204.80213.898.772,026,075125,616,697
26 Weeks234.68161.93163.6842.0372,428,639303,579,941
52 Weeks234.68115.94127.0083.0702,923,295736,670,353
YTD234.68209.36-9.272,027,28081,091,226
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
232.40231.58221.25195.54187.360.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.100.30.10
Income0.200.50.18
Dividend0.000.10.00
Capital Spending0.12NA0.21
R&D6.34NA10.78
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %4.94.97.1
Earnings %0.00.00.0
EPS %-94.6-94.618.9
EPS $-0.70-0.700.57
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio42.80
Current Ratio4.4
Quick Ratio (Acid Test)3.8
Liquidity Ratio (Cash)6.34
Receivables Turnover8.1
Average Collection Period44
Working Capital/Equity68.5
Working Capital pS17.70
Cash-Flow pS6.34
Free Cash-Flow pS5.43
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio10.88
Financial Leverage Ratio (Assets/Equity)0.3
Debt Ratio17.4
Total Debt/Equity (Gearing Ratio)0.28
LT Debt/Equity0.27
LT Debt/Capital Invested31.3
LT Debt/Total Liabilities96.7
Interest Cover29.7
Interest/Capital Invested0.64
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio5.66
Current P/E Ratio - LTM45.10
Enterprise Value (EV)/EBITDA28.20
Enterprise Value (EV)/Free Cash Flow40.98
Dividend Yield0.1
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM9.06
Price/Cash Flow Ratio36.9
Price/Free Cash Flow Ratio - LTM43.1
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM36.1
P/E Ratio (26 weeks ago) - LTM26.8
P/E Ratio (52 weeks ago) - LTM28.5
5-Y High P/E Ratio46.6
5-Y Low P/E Ratio11.2
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E61
P/E as % of Industry Group132.0
P/E as % of Sector Segment102.0
Current 12 Month Normalized P/E Ratio - LTM26.6
PER SHARE FIGURES
LT Debt pS6.98
Current Liabilities pS5.21
Tangible Book Value pS - LTM11.78
Book Value pS - LTM25.82
Capital Invested pS33.01
Cash pS - LTM0.00
Cash Flow pS - LTM6.34
Free Cash Flow pS - LTM5.43
Earnings pS (EPS)5.12
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin22.80
Free Cash Flow Margin 5YEAR AVG16.53
Net Profit Margin0.2
Net Profit Margin - 5YEAR AVRG.0.1
Equity Productivity0.93
Return on Equity (ROE)0.2
Return on Equity (ROE) - 5YEAR AVRG.0.2
Capital Invested Productivity0.73
Return on Capital Invested (ROCI)0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.1
Assets Productivity0.60
Return on Assets (ROA)0.1
Return on Assets (ROA) - 5YEAR AVRG.0.1
Gross Profit Margin88.4
Gross Profit Margin - 5YEAR AVRG.0.9
EBITDA Margin - LTM31.9
EBIT Margin - LTM28.4
Pre-Tax Profit Margin0.2
Pre-Tax Profit Margin - 5YEAR AVRG.0.2
Effective Tax Rate24.5
Effective Tax Rate - 5YEAR AVRG.36.0
EFFICIENCY RATIOS
Cash Conversion Cycle20,174,001
Revenue per Employee689,324
Net Income per Employee145,162
Average Collection Period20,174,001
Receivables Turnover8.1
Day's Inventory Turnover Ratio
Inventory Turnover2.9
Inventory/Sales4.1
Accounts Payble/Sales4.97
Assets/Revenue1.67
Net Working Capital Turnover1.36
Fixed Assets Turnover1.31
Total Assets Turnover0.6
Revenue per $ Cash1.47
Revenue per $ Plant7.19
Revenue per $ Common Equity0.93
Revenue per $ Capital Invested0.73
Selling, General & Adm/tive (SG&A) as % of Revenue39.2
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue16.5
R&D Expense as % of Revenue - 5YEAR AVRG.16.5

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nyse agn150228 11:00